GovChime
Notice ID: 97e901753b5d43e5a4cb3804a28697b6SolicitationArchived

In Vitro Assessments of Antimicrobial Activity

Archived on May 9, 2025. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
3:00 PM EDT
Posted
April 10, 2025
Notice type
Solicitation
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIAID
Place of performance
Bethesda, MD
Last updated
Nov 16, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
75N93024R00024
Notice ID
97e901753b5d43e5a4cb3804a28697b6

Description

AMENDMENT THREE The purpose of Amendment Three is to: 1. Provide a cut-off date for submission of questions; 2. Provide a new deadline for proposal submissions to eCPS; 3. Provide an updated SBCX (small business subcontract plans) link; and 4. Respond to questions received regarding this solicitation. ______________________________________________________________________ AMENDMENT TWO The purpose of Amendment Two is to: 1. Respond to questions received regarding this solicitation. ______________________________________________________________________ AMENDMENT ONE The purpose of Amendment One is to: 1. Provide a cut-off date for submission of questions; 2. Provide updated instructions for the Proposal Intent Response Sheet; 3. Clarify submission instructions to eCPS; and 4. Respond to questions received regarding this solicitation. ______________________________________________________________________ Introduction The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases. The NIAID, Division of Microbiology and Infectious Diseases (DMID), has a requirement to support in vitro testing assess the therapeutic potential of compounds to advance our understanding of infectious diseases as well as advance the development of therapeutics for infectious diseases. Description NIAID supports nearly all stages of the product development pipeline from in vitro therapeutic evaluation through advanced therapeutic and vaccine testing and manufacturing using multiple support services contracts. The current solicitation addresses a critical stage in this pipeline by providing an efficient means to assess the therapeutic potential of compounds through in vitro testing. The overarching goal of the In Vitro Assessments of Antimicrobial Activity program is to provide capability in a broad range of in vitro testing capabilities to assess promising candidate countermeasures against the more than 270 infectious agents and vectors that are within the purview of DMID. In addition to meeting the needs of extramural researchers, it is anticipated that contracts resulting from this solicitation will provide crucial data to be used by NIAID partners at other agencies within the Department of Health and Human Services. Such data will facilitate the advancement of promising candidate medical countermeasures against priority emerging and bioterror infectious agents to approval or licensure and, in some cases, eventual deposit in the Strategic National Stockpile. In 2019, fourteen (14) institutions were awarded base contracts under the In Vitro Assessments of Antimicrobial Activity IDIQ contract program. Its overarching goal was to provide broad capability in in vitro methods to evaluate activity of candidate countermeasures against the full range of infectious agents in the purview of DMID. The breadth of the existing contractor pool has enabled a rapid and effective response to emerging threats such as SARS-CoV-2 and other emergency preparedness priorities. NIAID anticipates awarding multiple Indefinite Delivery, Indefinite Quantity (IDIQ) contracts to organizations that have the capabilities required to fulfill the technical requirements of the Task Areas described below. Offerors may submit to multiple Task Areas where they are capable to best meet the overall Task Area requirements, however, they must submit separate proposals for each of these Task Areas. Offerors will be considered for contracts only in the Task Area(s) included in their proposal(s), and successful Contractors may compete for task orders only in the Task Area(s) in which they are selected for award. Sample Task Orders will be provided in the Request for Proposal (RFP) solely to evaluate Offeror responses and capabilities. The Task Areas of this solicitation are as follows: Task Area A Bacteria, Fungi, and Toxins Task Area B Viruses Task Area C Parasites and Vectors Task Area D New Techniques to Culture Difficult-to-Grow Pathogens The NIAID recognizes that a single organization or institution may not have the full spectrum of expertise, or facilities required to perform all activities set forth in the Statement of Work. Contractors may need to be supported to a certain extent by the expertise and resources of other organizations or persons through subcontracts, partnership or consortia agreements, and/or use of consultants. However, Contractors shall be responsible for ALL work performed and shall be responsible for project planning, initiation, implementation, management, and communication; evaluation, selection, and management of subcontractors; and for all deliverables specified in this contract and each awarded Task Order. Any responsible offeror may submit a proposal that will be considered by the Agency. This RFP will be available electronically on/about December 30, 2024, and may be accessed through SAM.gov. This notice does not commit the Government to award a contract. No collect calls will be accepted. No facsimile transmissions will be accepted. For this solicitation, the NIAID requires proposals to be submitted online via the NIAID electronic Contract Proposal Submission (eCPS) website. Submission of proposals by facsimile or e-mail is not acceptable. For directions on using eCPS, go to the website https://ecps.nih.gov and then click on "How to Submit." Follow the "How to Submit an Electronic Proposal" instructions provided on the eCPS website at: https://ecps.nih.gov/home/howto. Please note that creating an account to submit may take up to three (3) business days. Please apply for a new account early to allow enough time for the registration process.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

Files (22)

  • Amendment Three.pdf

    178 KBAdded in Solicitation version 9Posted
    Download
  • Amendment Two.pdf

    147 KBAdded in Solicitation version 6Posted
    Download
  • Amendment One.pdf

    154 KBAdded in Solicitation version 6Posted
    Download
  • RFP - 75N93024R00024.pdf

    690 KBAdded in Solicitation version 6Posted
    Download
  • Attachment 1 - Packaging and Delivery of Proposals for Use with the NIH eCPS.pdf

    201 KBAdded in Solicitation version 6Posted
    Download
  • Attachment 3 - Base IDIQ Statement of Work.pdf

    217 KBAdded in Solicitation version 6Posted
    Download
  • Attachment 4 - Sample Task Order A-01.pdf

    147 KBAdded in Solicitation version 6Posted
    Download
  • Attachment 5 - Sample Task Order A-02.pdf

    180 KBAdded in Solicitation version 6Posted
    Download
  • Attachment 6 - Sample Task Order B-01.pdf

    177 KBAdded in Solicitation version 6Posted
    Download
  • Attachment 7 - Sample Task Order C-01.pdf

    166 KBAdded in Solicitation version 6Posted
    Download
  • Attachment 8 - Sample Task Order D-01.pdf

    136 KBAdded in Solicitation version 6Posted
    Download
  • Attachment 10 - Technical Proposal Cost Summary.pdf

    164 KBAdded in Solicitation version 6Posted
    Download
  • Attachment 11 - Summary of Related Activities.pdf

    22 KBAdded in Solicitation version 6Posted
    Download
  • Attachment 12 - Additional Technical Proposal Instructions.pdf

    141 KBAdded in Solicitation version 6Posted
    Download
  • Attachment 13 - Additional Business Proposal Instructions.pdf

    173 KBAdded in Solicitation version 6Posted
    Download
  • Attachment 14 - Proposal Summary and Data Record (NIH-2043).pdf

    87 KBAdded in Solicitation version 6Posted
    Download
  • Attachment 15 - HHS Industry User Guide for Subcontracting Plan Reviews.pdf

    627 KBAdded in Solicitation version 6Posted
    Download
  • Attachment 17 - Offeror Points of Contact.pdf

    17 KBAdded in Solicitation version 6Posted
    Download
  • Attachment 18 - Disclosure of Lobbying Activities OMB Form SF-LLL.pdf

    1.8 MBAdded in Solicitation version 6Posted
    Download
  • Attachment 19 - NIH(RC)4.pdf

    235 KBAdded in Solicitation version 6Posted
    Download
  • Attachment 20 - NIH(RC)2.pdf

    136 KBAdded in Solicitation version 6Posted
    Download
  • Attachment 21 - Safety and Health HHSAR 352.223-70.pdf

    19 KBAdded in Solicitation version 6Posted
    Download

Lifecycle

  1. 4
    Version 4PresolicitationArchived

    In Vitro Assessments of Antimicrobial Activity

    Notice a25d8a263b6d4d9ab2bc81cb62143001 on SAM.gov

  2. 2
    Version 2SolicitationArchived

    Type changed from Presolicitation to Solicitation

    In Vitro Assessments of Antimicrobial Activity

    Notice cff5204bb6dc43089bd99951c921ad20 on SAM.gov

  3. 3
    Version 3SolicitationArchived

    In Vitro Assessments of Antimicrobial Activity

    Notice b96616c8513f4d528c997af700acdc93 on SAM.gov

  4. 6
    Version 6SolicitationArchived

    In Vitro Assessments of Antimicrobial Activity

    Notice f698d37c73ad4ba8ae6afba187c73171 on SAM.gov

  5. 7
    Version 7SolicitationArchived

    In Vitro Assessments of Antimicrobial Activity

    Notice 8b12d8ce2d514bf997844d1a32be4528 on SAM.gov

  6. 9
    Version 9SolicitationArchivedCurrent

    In Vitro Assessments of Antimicrobial Activity

    Notice 97e901753b5d43e5a4cb3804a28697b6 on SAM.gov

Other notices for this solicitation

  1. Market ResearchJul 24, 2024

    In Vitro Assessments of Antimicrobial Activity

    Notice 8104dbf45c984853b15a1450512e4ae1 on SAM.gov

  2. Pre-SolicitationDec 12, 2024

    In Vitro Assessments of Antimicrobial Activity

    Notice feaa675c27c242318df7afe79e3394a9 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N93024R00024

Archive Date

May 9, 2025

Office Address

BETHESDA, MD, 20892